Global Diabetic Therapeutic Market 2017-2021

Diabetic therapeutic market forecast

Technavio’s market research analysts predict the global diabetic therapeutic market to grow steadily during the forecast period and post a CAGR of more than 7% by 2021. This industry research report identifies the increasing focus on the self-management of diabetes to be one of the major factors that will have a positive impact on the growth of this market in the coming years. With the recent years witnessing an increase in number of people diagnosed with type 1 diabetes, there has been considerable increase in the adoption of insulin delivery systems.  Focusing on skipping the need to schedule appointments and reduce expenses for clinical visits, increases the adoption of insulin delivery systems, where individuals use insulin injections at home under the guidance of a physician. This led to the introduction of insulin pens, pumps, and jet injectors, which, in turn, will drive the growth of the diabetic therapeutics market.

 Get A Free Sample

In terms of geographical regions, the Americas will be the major revenue contributor to the diabetic therapeutics market throughout the predicted period. The increasing prevalence of diabetes in countries such as the US, which provides opportunities for vendors to develop new, more efficient, and safer drugs will be the major factor driving market growth in this segment.

Diabetic therapeutic market value: Competitive landscape and key vendors

Characterized by the presence of numerous small and large-scale vendors, the diabetes treatment market appears to be highly competitive. The market is dominated by the major players such as AstraZeneca, Novo Nordisk, Merck, Eli Lilly, and Sanofi who are competing against each other to lead the market. The market also consists of a number of local manufacturers in various countries and will also witness the entry of several new players, which will further intensify the level of competition in the market. To increase their revenue shares and improve market position, vendors are focusing on strategic alliances which will help them in marketing and manufacturing drugs.

The leading vendors in the market are

• AstraZeneca
• Eli Lilly
• Merck
• Novo Nordisk
• Sanofi

Segmentation by type of disease and analysis of the diabetic therapeutic market

• Type 1 diabetes
• Type 2 diabetes
• Gestational diabetes

During 2016, the type 1 diabetes segment accounted for the major shares and dominated the market. The increase in the global population diagnosed with type 1 diabetes and the rising awareness of the disease will be major factors aiding the growth of this market segment in the coming years.

Segmentation by drug class of disease and analysis of the diabetic therapeutic market

• Insulin therapies
• Non-insulin therapies

Insulin therapies are mostly adopted for the most advanced stage of diabetes and are used to compensate for the inadequate production of endogenous insulin. According to the diabetes treatment market research and analysis, the insulin therapies segment accounted for the major shares and dominated the market during 2016.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global diabetic therapeutic market?
• What are the key market trends impacting the growth of the global diabetic therapeutic market?
• What are the challenges to market growth?
• Who are the key vendors in the global diabetic therapeutic market?
• What are the market opportunities and threats faced by the vendors in the global diabetic therapeutic market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global diabetic therapeutic market?

Technavio also offers customization on reports based on specific client requirement.